Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis.
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.
Experimental autoimmune encephalomyelitis in the mouse.
Mouse models for multiple sclerosis: historical facts and future implications.
Precision medicine in chronic disease management: The MS BioScreen.
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
Mycophenolate mofetil in multiple sclerosis.
Unusual association of Arnold-Chiari malformation and vitamin B12 deficiency.
Safety study of BIIB033 in subjects with multiple sclerosis
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.
A regenerative approach to the treatment of multiple sclerosis.
Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement
Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
CellCept Drug Details
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.

Pages